Approval · Notice of Compliance 9426 · 2008
RAMIPRIL: Notice of Compliance 9426
Issued March 14, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9426
- Date
- March 14, 2008
- Company
- Laboratoire Riva Inc.Blainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Angiotensin converting enzyme inhibitor
- Canadian reference product
- ALTACE (Hoechst Marion Roussel Canada Inc.)